JOIN Enterprise expands global reach with fiberglass casting tape and splints

JOIN Enterprise Co., Ltd. is pushing deeper into overseas markets with orthopedic casting tape and splint products now sold in more than 50 countries. The South Korean manufacturer is also moving its medical-grade material technology into consumer healthcare, starting with a hydrocolloid acne patch launched in 2025.

Why it matters: - JOIN Enterprise is extending a hospital-tested orthopedic product line into more global markets. - The company’s products are positioned as alternatives to traditional plaster casts, with lighter materials and faster curing. - The expansion into consumer healthcare shows the company trying to turn medical device know-how into new product categories.

What happened: - JOIN Enterprise Co., Ltd., a South Korean orthopedic device manufacturer, said it is strengthening its global market position with synthetic fiberglass casting tape and orthopedic splint systems. - The company said its exports now reach more than 50 countries, including North America and Europe. - JOIN Enterprise said it will meet global buyers and partners at MEDICA in Dusseldorf, Germany, at Hall 5, Booth K12.

The details: - JOIN Enterprise has focused exclusively on orthopedic immobilization devices for more than 30 years. - The fiberglass casting tape is designed as a replacement for plaster casts. - The product is described as lightweight, high-strength, fast-curing and easy to mold. - The splint products are used in hospitals and medical institutions to stabilize and protect injured limbs. - JOIN Enterprise said each cast and splint product is made under a quality management system built on three decades of production technology and ongoing R&D investment. - The company said its hydrocolloid acne patch launched in 2025 uses medical-grade material technology for skin protection and blemish care. - JOIN Enterprise said the acne patch is designed to offer enhanced safety and adhesion through medical device-level quality standards. - The company’s website is joinenterprise.com.

Between the lines: - JOIN Enterprise is using its regulated medical-device background as a credibility signal while broadening beyond orthopedic care. - The move into consumer healthcare suggests the company sees commercial upside in applying the same materials and quality controls to everyday products. - Participation at MEDICA signals a continued focus on international distribution and partner building.

What's next: - JOIN Enterprise said it plans to keep advancing orthopedic device technology. - The company also plans to expand its global footprint and develop more medical device-based consumer healthcare products. - Continued international sales and trade-show outreach will likely remain central to the company’s growth strategy.

The bottom line: - JOIN Enterprise is betting that hospital-grade materials and manufacturing discipline can support both global orthopedic sales and a broader consumer health push.